Financial information, reports, calendar and more
Interim Report Q2 – August 23, 2018
Interim Report Q3 – November 16, 2018
Affibodys latest Press releases
Affibody in short
Affibody is a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.
Upcoming reports Financial calendar
- Interim Report Q2 (August 23, 2018)